Prostate cancer
Results
Phase 3
This trial was done to compare 3 treatment options for prostate cancer that is contained within the prostate gland. This is called localised cancer.
The treatment options were radiotherapy, surgery and active monitoring. The trial was done because doctors weren’t sure if any one treatment was better than another for men in this situation.
It was open for people to join between 1999 and 2009. The team published long term results in 2023.
Recruitment start: 1 October 2001
Recruitment end: 20 January 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor FC Hamdy
Professor JL Donovan
Professor DE Neal
NIHR Health Technology Assessment (HTA) programme
University of Oxford
University of Bristol
University of Cambridge
Cancer Research UK
NIHR Oxford Biomedical Research Centre
NIHR CLAHRC West
You can read more on the ProtecT trial website.
Last reviewed: 9 May 2023
CRUK internal database number: 117